The use of ketamine at sub-therapeutic doses for non-anesthesia purposes.
treats CRPS/RSD and other non-cancer pain
potentiates pain relief in opioid-tolerant treatment of certain psychological conditions
HBOT can improve dysexecutive functions, psychiatric symptoms (depression, anxiety and somatisation), pain interference symptoms and fatigue of patients suffering from post-COVID condition.
Restoration of glutathione levels in COVID-19 patients would be a promising approach for the management of the novel coronavirus SARS-CoV-2.
The anesthesia drug ketamine and a related medicine called esketamine appear to be safe for tough-to-treat depression, researchers report.
The anesthesia medication ketamine is showing increased promise as a treatment for people experiencing depression who haven't found relief with other prescription medications.